Beige mouse model for Mycobacterium avium complex disease
Open Access
- 1 August 1995
- journal article
- review article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 39 (8) , 1647-1654
- https://doi.org/10.1128/aac.39.8.1647
Abstract
No abstract availableThis publication has 69 references indexed in Scilit:
- In-vivo activity of streptomycin and clofazimine against established infections of Mycobacterium avium complex in beige miceJournal of Antimicrobial Chemotherapy, 1992
- Activity of rifapentine against Mycobacterium avium infection in beige miceJournal of Antimicrobial Chemotherapy, 1992
- An Animal Model of Mycobacterium avium Complex Disseminated Infection after Colonization of the Intestinal TractThe Journal of Infectious Diseases, 1992
- Thiacetazone: in vitro activity against mycobacterium avium and m. tuberculosisTubercle, 1990
- Animal models as predictors of the safety and efficacy of antibioticsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- The beige mouse model for mycobacterium avium complex (MAC) disease: Optimal conditions for the host and parasiteTubercle, 1989
- Activity of rifabutin alone and in combination with clofammine, kanamycin and ethambutol against Mycobacterium intracellulare infections in miceTubercle, 1989
- In Vitro and In Vivo Activity of Azithromycin (CP 62,993) Against the Mycobacterium avium ComplexThe Journal of Infectious Diseases, 1989
- Plasmid DNA Profiles as Epidemiological Markers for Clinical and Environmental Isolates of Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceumThe Journal of Infectious Diseases, 1986
- Experimental Infections with Mycobacterium intracellulareClinical Infectious Diseases, 1981